TABLE 2.

Description of the Primary Treatment Setting and ADT use Among Men with a History of Prostate Cancer^*

Primary Treatment Setting	Total PCa Patients, N (%)	Received ADT, N (%)	Avg ADT Exposure Months, Mean (SD)	ADT > 12 Months, N (%)
Surgery	225 (64.8)	44 (44.4)	88.4 (77.7)	31 (57.4)
Radiation	138 (39.8)	60 (60.6)	41.1 (64.0)	22 (40.7)
Metastasis	41 (11.8)	26 (26.3)	71.0 (70.6)	19 (35.2)

ADT, Androgen deprivation therapy; PCa, Prostate cancer

^*The treatment groups are not mutually exclusive.